LABT

Lakewood-Amedex Biotherapeutics Inc. LABT

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$166.7K total
Marex Group plc
$151.2K--
UBS Group AG
$12.9K--
Tower Research Capital LLC (TRC)
$2.0K--
OSAIC HOLDINGS, INC.
$433--
HRT FINANCIAL LP
$140--
Ronald Blue Trust, Inc.
$35--
See all 6 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/LABT

Earnings Per Share

13fpro.ai/company/LABT

Loading ratio trend…

About Lakewood-Amedex Biotherapeutics Inc. (LABT): stock profile, AI score and financials

Lakewood-Amedex Biotherapeutics Inc. (LABT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. LABT is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of LABT by reported 13-F value include Marex Group plc, UBS Group AG, Tower Research Capital (TRC), based on the most recent SEC filings. LABT trades on the Nasdaq exchange and files with the SEC under CIK 2079272. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LABT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Lakewood-Amedex Biotherapeutics Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 2079272 →